Real World Evidence (RWE) 

A RCT published in JMCP found that automated telephonic outreach did not increase vaccination rates amongst community pharmacy patients.

AMCP and AMCP Foundation have set forth a four-part research agenda that identifies and prioritizes critical evidentiary gaps in managed care pharmacy.

A RCT published in JMCP found that automated telephonic outreach did not increase vaccination rates amongst community pharmacy patients.

A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents.

A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents.

Patients with treatment resistant depression use more resources and have significantly higher health care costs, according to a retrospective cohort published in JMCP.

A cost impact analysis of Medicare patients with Alzheimer's disease and dementia in their final years of life found that families and Medicaid bear the bear most of the cost burden. The authors of this JMCP article propose the need to better integrate Medicare and Medicaid to fund and improve patient outcomes.

A cost impact analysis of Medicare patients with Alzheimer's disease and dementia in their final years of life found that families and Medicaid bear the bear most of the cost burden. The authors of this JMCP article propose the need to better integrate Medicare and Medicaid to fund and improve patient outcomes.

Patients with treatment resistant depression use more resources and have significantly higher health care costs, according to a retrospective cohort published in JMCP.

The Academy of Managed Care Pharmacy (AMCP) supports scientifically sound research that compares the effectiveness and value of prescription drugs, as well as research aimed at tailoring treatment options to individual patients’ needs.

In diabetic patients, treatment intensification with insulin or GLP-1RA after failure of two oral anti-diabetic agents resulted in improved glycemic control, according to a retrospective cohort published in JMCP.